MARAVAI LIFESCIENCES ELECTS GREGORY T. LUCIER TO BOARD OF DIRECTORS
January 9, 2020
Industry veteran brings business building experience to growing life science company SAN DIEGO – Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech partners, today announced that Gregory T. Lucier has been elected to its board of directors. Mr. Lucier, a 25-year veteran of the healthcare industry, is currently [...]
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
January 9, 2020
Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform SAN DIEGO -- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announced it has raised an additional $60 million with the completion of its Series C financing. The funding round was led by Madrone [...]
January 9, 2020
BRANFORD, Conn. -- Isoplexis the leader in single-cell functional proteomics, has announced today that it has raised an additional $20 million in its Series C financing, bringing the entire Series C round to $45 million. The funding will continue to drive the global commercial expansion of its IsoLight single-cell proteomic analysis platform. The recent financing was led by Northpond Ventures, [...]
SP Scientific launches the HT Series 3i Evaporators
January 9, 2020
New high-throughput, high-speed evaporator range significantly increases ease of use, with reduced environmental impact HT Series 3i Evaporator IPSWICH, UK – SP Scientific has announced the launch of the HT Series 3i Evaporators, the updated replacements for the highly successful HT Series 3 evaporator range. Already established as the ultimate in solvent removal technology, the new HT Series 3i [...]
Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio
January 8, 2020
LOS ANGELES -- Calibre Scientific is pleased to announce that it has completed the acquisition of the NeXtal Biotechnologies line of structural biology products from Qiagen NV (QGEN). NeXtal specializes in the production of unique screens and plates for protein crystallization, an important step in the complex process of structural biology studies and structure-based drug design. [...]
ZAGENO Bolsters Leadership with Appointment of CFO, Robert Cruickshank
January 8, 2020
CAMBRIDGE, Mass. and BERLIN -- ZAGENO, a leading enterprise marketplace solution connecting e-commerce to life science, today announced that Robert Cruickshank will join the company as chief financial officer, effective January 13. “We are very excited to welcome Bob to our team. His expertise in the finance requirements of high growth start-ups and mature stage [...]
January 8, 2020
NEW YORK -- Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of [...]
January 8, 2020
Certara’s Simcyp® Simulator’s MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product. Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Galderma’s successful U.S. Food and Drug Administration (FDA) new [...]
January 8, 2020
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante [...]
Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round
January 8, 2020
DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap [...]
